Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Sita, Gourishankar"'
Autor:
Rachel Jeong, Robert R. Quinn, Krista L. Lentine, Pietro Ravani, Feng Ye, Patricia Campbell, Kevin Wen, Chris Broscheit, Sita Gourishankar, Ngan N. Lam
Publikováno v:
Canadian Journal of Kidney Health and Disease, Vol 7 (2020)
Background: Kidney transplant recipients are given induction therapy to rapidly reduce the immune response and prevent rejection. Guidelines recommend that an interleukin-2 receptor antibody (basiliximab) be the first-line agent and that a lymphocyte
Externí odkaz:
https://doaj.org/article/65b0842772c64e01bcf432589a6418d2
Autor:
Rachel Jeong, Robert R. Quinn, Krista L. Lentine, Anita Lloyd, Pietro Ravani, Brenda Hemmelgarn, Branko Braam, Amit X. Garg, Kevin Wen, Anita Wong-Chan, Sita Gourishankar, Ngan N. Lam
Publikováno v:
Canadian Journal of Kidney Health and Disease, Vol 6 (2019)
Background: Calcineurin inhibitors (CNI; cyclosporine, tacrolimus) are critical for kidney transplant immunosuppression, but have multiple potential drug interactions, such as with macrolide antibiotics. Macrolide antibiotics (clarithromycin, erythro
Externí odkaz:
https://doaj.org/article/82e76dc0f4ac4f43bce3f80cd8476ef9
Autor:
Ngan N. Lam, Krista L. Lentine, Brenda Hemmelgarn, Scott Klarenbach, Robert R. Quinn, Anita Lloyd, Sita Gourishankar, Amit X. Garg
Publikováno v:
Canadian Journal of Kidney Health and Disease, Vol 5 (2018)
Background: Previous guidelines recommend that living kidney donors receive lifelong annual follow-up care to assess renal health. Objective: To determine whether these best practice recommendations are currently being followed. Design: Retrospective
Externí odkaz:
https://doaj.org/article/a1ab1bfa75d34e3a8b4fcd480ce19eb8
Publikováno v:
Clinical drug investigation. 42(3)
Mycophenolic acid (MPA) is a commonly prescribed life-long immunosuppressant for kidney transplant recipients. The frequently observed large variations in MPA plasma exposure may lead to severe adverse outcomes; therefore, characterizations of contri
Autor:
Pietro Ravani, Feng Ye, Krista L. Lentine, Sita Gourishankar, Ngan N. Lam, Robert R. Quinn, Rachel Jeong, Chris Broscheit, Patricia Campbell, Kevin Wen
Publikováno v:
Canadian Journal of Kidney Health and Disease, Vol 7 (2020)
Canadian Journal of Kidney Health and Disease
Canadian Journal of Kidney Health and Disease
Kidney transplant recipients are given induction therapy to rapidly reduce the immune response and prevent rejection. Guidelines recommend that an interleukin-2 receptor antibody (basiliximab) be the first-line agent and that a lymphocyte-depleting a
Autor:
Arthur J. Matas, Sita Gourishankar, David N. Rush, Roslyn B. Mannon, Fernando G. Cosio, Bertram L. Kasiske, Robert S. Gaston, John E. Connett, Erika S. Helgeson, Lawrence G. Hunsicker, Joseph P. Grande, Michael Cecka
Publikováno v:
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant SurgeonsREFERENCES. 21(5)
Inflammation in areas of fibrosis (i-IFTA) in posttransplant biopsies is part of the diagnostic criteria for chronic active TCMR (CA TCMR -- i-IFTA ≥ 2, ti ≥ 2, t ≥ 2). We evaluated i-IFTA and CA TCMR in the DeKAF indication biopsy cohorts: pro
Autor:
Lawrence G. Hunsicker, J. Michael Cecka, Roslyn B. Mannon, Erika S. Helgeson, Sita Gourishankar, Arthur J. Matas, Fernando G. Cosio, John E. Connett, Bertram L. Kasiske, David N. Rush, Joseph P. Grande, Robert S. Gaston
Publikováno v:
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant SurgeonsREFERENCES. 20(9)
Inflammation in areas of fibrosis (i-IFTA) in posttransplant biopsy specimens has been associated with decreased death-censored graft survival (DC-GS). Additionally, an i-IFTA score ≥ 2 is part of the diagnostic criteria for chronic active TCMR (CA
Autor:
Robert E Leduc, Fernando G. Cosio, Arthur J. Matas, Bertram L. Kasiske, Sita Gourishankar, Ann M. Fieberg, J. Michael Cecka, John E. Connett, Joseph P. Grande, Roslyn B. Mannon, Lawrence G. Hunsicker, David N. Rush, Robert S. Gaston
Publikováno v:
American Journal of Transplantation. 18:1158-1167
Beyond the first posttransplant year, 3% of kidney transplants fail annually. In a prospective, multicenter cohort study, we tested the relative impact of early versus late events on risk of long-term death-censored graft failure (DCGF). In grafts su
Autor:
Brenda R. Hemmelgarn, Sita Gourishankar, Kevin Wen, Branko Braam, Ngan N. Lam, Anita Wong-Chan, Rachel Jeong, Anita Lloyd, Pietro Ravani, Robert R. Quinn, Krista L. Lentine, Amit X. Garg
Publikováno v:
Canadian Journal of Kidney Health and Disease, Vol 6 (2019)
Canadian Journal of Kidney Health and Disease
Canadian Journal of Kidney Health and Disease
Calcineurin inhibitors (CNI; cyclosporine, tacrolimus) are critical for kidney transplant immunosuppression, but have multiple potential drug interactions, such as with macrolide antibiotics. Macrolide antibiotics (clarithromycin, erythromycin, and a
Autor:
Debora L. Hogan, Norman Muirhead, Michel Paquet, John S. Gill, Valerie Cronin, Lee Anne Tibbles, Christine A. White, Darin Treleaven, Greg Knoll, Tim Ramsay, George A. Wells, Dean Fergusson, David C. Holland, Marcelo Cantarovich, Sita Gourishankar, Ramesh Prasad, Jean Shapiro, Michaël Chassé, Bryce A. Kiberd, Edward Cole, Helen Pilmore, Paul C. Hébert
Publikováno v:
The Lancet Diabetes & Endocrinology. 4:318-326
Summary Background Angiotensin-converting enzyme inhibitors have been shown to reduce the risk of end-stage renal disease and death in non-transplant patients with proteinuria. We examined whether ramipril would have a similar beneficial effect on im